Correlation Between RPBio and Medy Tox
Can any of the company-specific risk be diversified away by investing in both RPBio and Medy Tox at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RPBio and Medy Tox into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RPBio Inc and Medy Tox, you can compare the effects of market volatilities on RPBio and Medy Tox and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RPBio with a short position of Medy Tox. Check out your portfolio center. Please also check ongoing floating volatility patterns of RPBio and Medy Tox.
Diversification Opportunities for RPBio and Medy Tox
Very poor diversification
The 3 months correlation between RPBio and Medy is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding RPBio Inc and Medy Tox in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medy Tox and RPBio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RPBio Inc are associated (or correlated) with Medy Tox. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medy Tox has no effect on the direction of RPBio i.e., RPBio and Medy Tox go up and down completely randomly.
Pair Corralation between RPBio and Medy Tox
Assuming the 90 days trading horizon RPBio Inc is expected to generate 0.95 times more return on investment than Medy Tox. However, RPBio Inc is 1.05 times less risky than Medy Tox. It trades about -0.04 of its potential returns per unit of risk. Medy Tox is currently generating about -0.05 per unit of risk. If you would invest 524,000 in RPBio Inc on October 26, 2024 and sell it today you would lose (9,000) from holding RPBio Inc or give up 1.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
RPBio Inc vs. Medy Tox
Performance |
| Timeline |
| RPBio Inc |
| Medy Tox |
RPBio and Medy Tox Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RPBio and Medy Tox
The main advantage of trading using opposite RPBio and Medy Tox positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RPBio position performs unexpectedly, Medy Tox can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medy Tox will offset losses from the drop in Medy Tox's long position.| RPBio vs. Alton Sports CoLtd | RPBio vs. Samlip General Foods | RPBio vs. Korea Air Svc | RPBio vs. Air Busan Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |